Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chlamydia Infections - Overview
Chlamydia Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Chlamydia Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chlamydia Infections - Companies Involved in Therapeutics Development
Abera Bioscience AB
Abivax SA
BlueWillow Biologics Inc
Erganeo
Eurocine Vaccines AB
Evofem Biosciences Inc
Genetic Immunity Inc
Lawrence Livermore tiol Laboratory
Lead Discovery Center GmbH
Merck & Co Inc
Microbiotix Inc
Prokarium Ltd
QureTech Bio AB
Traccine Pharmaceuticals
Vault Pharma Inc
Vaxine Pty Ltd
Yaso Therapeutics Inc
Chlamydia Infections - Drug Profiles
(citric acid + lactic acid + potassium bitartrate) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Ab-03 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ABX-196 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ChlamyDerm - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia trachomatis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PEG-2S - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide to Inhibit CPAF for Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PPCM - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Block Virulence for Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit 16S rR for Gonorrhea and Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
solithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VPI-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia Infections - Dormant Projects
Chlamydia Infections - Product Development Milestones
Featured News & Press Releases
May 12, 2020: Eurocine Vaccines receives notification of grant to prepare for the manufacture of the chlamydia vaccine candidate
May 07, 2020: Eurocine Vaccines presents end results from preclinical study with chlamydia vaccine
Jan 27, 2020: Eurocine Vaccines launches new preclinical study with chlamydia vaccine candidate
Aug 13, 2019: Progress made in developing first Chlamydia vaccine
Mar 13, 2019: Yaso Therapeutics awarded $2 million SBIR grant from the tiol Institutes of Health to complete preclinical studies of a new female contraceptive that prevents disease transmission
Sep 26, 2018: BlueWillow Biologics awarded grant for chlamydia vaccine development
Apr 20, 2017: New weapon in fight against antibiotic resistance discovered
Dec 02, 2015: noBio’s Chlamydia Vaccine Improves Clearance of Bacteria and Prevents Pelvic Inflammatory Disease in Mice
Aug 03, 2015: New Vaccine For Chlamydia to Use Synthetic Biology
Aug 03, 2015: SynbiCITE funds new vaccine for Chlamydia
Aug 12, 2014: Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection
Jul 20, 2011: Newly Designed Molecule Blocks Chlamydia Bacteria
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Chlamydia Infections, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Chlamydia Infections, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Chlamydia Infections - Pipeline by Abera Bioscience AB, H2 2020
Chlamydia Infections - Pipeline by Abivax SA, H2 2020
Chlamydia Infections - Pipeline by BlueWillow Biologics Inc, H2 2020
Chlamydia Infections - Pipeline by Erganeo, H2 2020
Chlamydia Infections - Pipeline by Eurocine Vaccines AB, H2 2020
Chlamydia Infections - Pipeline by Evofem Biosciences Inc, H2 2020
Chlamydia Infections - Pipeline by Genetic Immunity Inc, H2 2020
Chlamydia Infections - Pipeline by Lawrence Livermore National Laboratory, H2 2020
Chlamydia Infections - Pipeline by Lead Discovery Center GmbH, H2 2020
Chlamydia Infections - Pipeline by Merck & Co Inc, H2 2020
Chlamydia Infections - Pipeline by Microbiotix Inc, H2 2020
Chlamydia Infections - Pipeline by Prokarium Ltd, H2 2020
Chlamydia Infections - Pipeline by QureTech Bio AB, H2 2020
Chlamydia Infections - Pipeline by Traccine Pharmaceuticals, H2 2020
Chlamydia Infections - Pipeline by Vault Pharma Inc, H2 2020
Chlamydia Infections - Pipeline by Vaxine Pty Ltd, H2 2020
Chlamydia Infections - Pipeline by Yaso Therapeutics Inc, H2 2020
Chlamydia Infections - Dormant Projects, H2 2020